| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 05/05/2011 | US20110105508 Quinoxaline and quinoline derivatives as kinase inhibitors |
| 05/05/2011 | US20110105493 HETEROCYCLYL SUBSTITUTED ARYLINDENOPYRIMIDINES AND THEIR USE AS HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 05/05/2011 | US20110105492 ARYL SUBSTITUTED ARYLINDENOPYRIMIDINES AND THEIR USE AS HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 05/05/2011 | US20110105483 Triazole compounds that modulate hsp90 activity |
| 05/05/2011 | US20110105472 Diaminopyrimidines as crop protection agents |
| 05/05/2011 | US20110105463 6-substituted phenoxychroman carboxylic acid derivatives |
| 05/05/2011 | US20110105460 Triazole derivative or salt thereof |
| 05/05/2011 | US20110105459 Azetidines and cyclobutanes as histamine h3 receptor antagonists |
| 05/05/2011 | US20110105456 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 05/05/2011 | US20110105455 Phenoxy-substituted pyrimidines as opioid receptor modulators |
| 05/05/2011 | US20110105447 Novel modulators of calcium release-activated calcium channel |
| 05/05/2011 | US20110105440 HEXAHYDROCYCLOPENTYL[f]INDAZOLE SULFONAMIDES AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS |
| 05/05/2011 | US20110104207 Gyrase inhibitors and uses thereof |
| 05/05/2011 | US20110104115 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 05/05/2011 | US20110104110 Substituted indole derivatives and methods of use thereof |
| 05/05/2011 | US20110104071 Methods and systems for spatially identifying abnormal cells |
| 05/05/2011 | US20110104043 Instrument and process for nanoparticles production in continuous flow mode |
| 05/05/2011 | DE112009001538T5 Zusammensetzung und unter Verwendung der Zusammensetzung hergestelltes Lichtemissionselement Composition and prepared using the composition of the light emitting element |
| 05/05/2011 | DE102009051172A1 Materialien für elektronische Vorrichtungen Materials for electronic devices |
| 05/05/2011 | CA2779452A1 2-aminoindole compounds and methods for the treatment of malaria |
| 05/05/2011 | CA2779107A1 Pyrimidine compounds as delta opioid receptor modulators |
| 05/05/2011 | CA2779095A1 Alkyl substituted arylindenopyrimidines and their use as highly selective adenosine a2a receptor antagonists |
| 05/05/2011 | CA2779083A1 Pyrazines as delta opioid receptor modulators |
| 05/05/2011 | CA2778979A1 Phenoxy-substituted pyrimidines as opioid receptor modulators |
| 05/05/2011 | CA2777896A1 Androgen receptor modulating compounds |
| 05/05/2011 | CA2777632A1 Imidazole derivatives as casein kinase inhibitors |
| 05/04/2011 | EP2316831A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer |
| 05/04/2011 | EP2316828A1 Piperazine derivatives and their use as therapeutic agents |
| 05/04/2011 | EP2316459A1 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| 05/04/2011 | EP2315764A2 Crystalline form of sunitinib and processes for its preparation |
| 05/04/2011 | EP2315763A1 Benzimidazoles and related analogs as sirtuin modulators |
| 05/04/2011 | EP2315760A1 Piperazine compounds with herbicidal effect |
| 05/04/2011 | EP2315753A2 Material for organic photoelectric device and organic photoelectric device including the same |
| 05/04/2011 | EP2315749A2 New therapeutic agents |
| 05/04/2011 | EP2315591A1 Novel pyrrole inhibitors of s-nitrosoglutathione reductase as therapeutic agents |
| 05/04/2011 | EP2315590A1 Pyrrole inhibitors of s-nitrosoglutathione reductase |
| 05/04/2011 | EP2315588A1 6-1h-imidazo-quinazoline and quinolines derivatives, new mao inhibitors and imidazoline receptor ligands |
| 05/04/2011 | EP2315521A1 Diamino-pyridine, pyrimidine, and pyridazine modulators of the histamine h 4 receptor |
| 05/04/2011 | EP2213669A9 Crystalline imidazol-5-carboxylic acid derivate |
| 05/04/2011 | EP2052033B1 Squarylium compound, optical recording medium using the same, recording/reproduction method and optical recording apparatus |
| 05/04/2011 | EP1981876B1 Triazoloanilinopyrimidine derivatives for use as antiviral agents |
| 05/04/2011 | EP1951716B1 Aminopyrimidines useful as kinase inhibitors |
| 05/04/2011 | EP1794122B1 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase i |
| 05/04/2011 | EP1633724B1 Phthalazinone derivatives |
| 05/04/2011 | EP1317448B2 Pyrazole compounds useful as protein kinase inhibitors |
| 05/04/2011 | EP1252156B1 Blockade of voltage dependent sodium channels |
| 05/04/2011 | CN1968949B Proline derivatives and their use as dipeptidyl peptidase IV inhibitors |
| 05/04/2011 | CN1956954B Novel androgens |
| 05/04/2011 | CN1918131B Novel inhibitors of glutaminyl cyclase |
| 05/04/2011 | CN102046610A Phenyl piperazine compounds, pharmaceutical composition including the same, and use thereof |
| 05/04/2011 | CN102046596A Substituted cyclohexyldiamines |
| 05/04/2011 | CN102046240A Novel P2X7R antagonists and their use |
| 05/04/2011 | CN102040589A Condensed-cyclic compound and organic light emitting diode |
| 05/04/2011 | CN101337980B Ruthenium complexes for restraining DNA from topologizing isomerase , preparation method and application thereof |
| 05/04/2011 | CN101180278B 2-amino-4-phenylquinazoline derivates and their use as HSP90 modulators |
| 05/04/2011 | CN101103005B Quinazoline derivatives, preparation methods and uses thereof |
| 05/03/2011 | US7935816 Molecular transporter compositions comprising dendrimeric oligoguanidine with a triazine core that facilitate delivery into cells in vivo |
| 05/03/2011 | US7935719 N-substituted-azacyclylamines as histamine-3 antagonists |
| 05/03/2011 | US7935715 Compounds which modulate the CB2 receptor |
| 05/03/2011 | US7935708 Dihydropyrazolopyrimidinone derivatives |
| 05/03/2011 | US7935703 Piperazines and piperidines as Mglur5 potentiators |
| 05/03/2011 | US7935698 Heteroaryl-hydrazone compounds |
| 05/03/2011 | US7935693 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as Axl inhibitors |
| 05/03/2011 | CA2528920C Cyclo(hetero)alkenyl compounds useful for treating pain |
| 05/03/2011 | CA2489824C Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases |
| 05/03/2011 | CA2476343C 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors |
| 05/03/2011 | CA2440438C Heterocyclic compounds |
| 05/03/2011 | CA2439709C Aryl and heteroaryl urea chki inhibitors for use as radiosensitizers and chemosensitizers |
| 05/03/2011 | CA2438480C Glucocorticoid receptor modulators |
| 05/03/2011 | CA2415010C Propane-1,3-dione derivatives useful as gnrh receptor antagonist |
| 04/28/2011 | WO2011050068A2 Bivalent diazo bicyclic smac mimetics and the uses thereof |
| 04/28/2011 | WO2011049520A1 Adamantyl iminocarbonyl-substituted pyrimidines as inhibitors of 1 1 betahsd1 |
| 04/28/2011 | WO2011048525A1 Novel heteroaryl imidazoles and heteroaryl triazoles as gamma-secretase modulators |
| 04/28/2011 | WO2011048032A1 Diazepam derivatives as modulators of chemokine receptors |
| 04/28/2011 | WO2011047432A1 Fused ring analogues of anti-fibrotic agents |
| 04/28/2011 | WO2011021224A3 Improved process for preparing (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[4-[2-(tetrazol-5-yl)phenyl]phenyl]methylimidazole-5-carboxylate |
| 04/28/2011 | WO2011021216A3 Improved process for preparing 4-(l, l-dimethylethyl)-n-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-[2,2' -bipyrimid in]-4-yl]benzene sulfonamide |
| 04/28/2011 | WO2011009084A3 Benzimidazole analogues for the treatment or prevention of flavivirus infections |
| 04/28/2011 | WO2010038086A8 P38 map kinase inhibitors |
| 04/28/2011 | US20110098483 Substituted Nitrogen Heterocycles and Synthesis and Uses Thereof |
| 04/28/2011 | US20110098468 Nk1 antagonists |
| 04/28/2011 | US20110098467 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 04/28/2011 | US20110098441 Label target and labeling reagents comprising backbones with at least two consecutive peptide bonds |
| 04/28/2011 | US20110098329 Catalyzed carbonylation in the synthesis of angiotensin ii antagonists |
| 04/28/2011 | US20110098310 Novel compounds, use and preparation thereof |
| 04/28/2011 | US20110098301 Pyrimidine Derivatives for Treatment of Hyperproliferative Disorders |
| 04/28/2011 | US20110098299 Spirolactam derivatives and uses of same |
| 04/28/2011 | US20110098290 Pharmaceutical compounds |
| 04/28/2011 | US20110098288 Sulfonamides as zap-70 inhibitors |
| 04/28/2011 | US20110098286 (3-aryl-piperazin-1-yl), (2-aryl-morpholin-4-yl) and (2-aryl-thiomorpholin-4-yl) derivatives of 6,7-dialkoxy-quinazoline, 6,7-dialkoxyphtalazine and 6,7-dialkoxyisoquinoline |
| 04/28/2011 | US20110098285 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 04/28/2011 | US20110098283 3-cinnolinecarboxamide derivatives and their use for treating cancer |
| 04/28/2011 | US20110098280 2,4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 04/28/2011 | US20110098277 Fab I Inhibitors |
| 04/28/2011 | US20110098272 Novel Compounds As Casein Kinase Inhibitors |
| 04/28/2011 | US20110098269 Substituted Pyridazinone Derivatives as Histamine-3 (H3) Receptor Ligands |
| 04/28/2011 | US20110098236 Diamide inhibitors of cytochrome p450 |
| 04/28/2011 | US20110097305 Gem-Disubstituted and Spirocyclic Amino Pyridines/Pyrimidines as Cell Cycle Inhibitors |
| 04/28/2011 | US20110097268 Radiohaloimatinibs and methods of their synthesis and use in pet imaging of cancers |
| 04/28/2011 | US20110094694 Fluorescent whitening agent compositions |